• Cat-intel
  • MedIntelliX
  • Resources
  • About Us
  • Request Free Sample ×

    Kindly complete the form below to receive a free sample of this Report

    Leading companies partner with us for data-driven Insights

    clients tt-cursor

    Gynecomastia Procedure Market

    ID: MRFR/HC/35375-HCR
    100 Pages
    Rahul Gotadki
    September 2025

    Gynecomastia Procedure Market Research Report By Procedure Type (Liposuction, Mastectomy, Thyroid Hormone Therapy, Medications, Ultrasound), By End User (Hospitals, Specialty Clinics, Ambulatory Surgical Centers), By Gender (Male, Female), By Age Group (Adolescents, Adults, Elderly) and By Regional (North America, Europe, South America, Asia Pacific, Middle East and Africa) - Forecast to 2035

    Share:
    Download PDF ×

    We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

    Gynecomastia Procedure Market Infographic
    Purchase Options

    Gynecomastia Procedure Market Summary

    The global gynecomastia procedure market is projected to grow from 2.52 USD billion in 2024 to 4.23 USD billion by 2035.

    Key Market Trends & Highlights

    Gynecomastia Procedure Key Trends and Highlights

    • The market is expected to experience a compound annual growth rate of 4.81 percent from 2025 to 2035.
    • By 2035, the market valuation is anticipated to reach 4.22 USD billion, indicating robust growth.
    • in 2024, the market is valued at 2.52 USD billion, reflecting a significant demand for gynecomastia procedures.
    • Growing adoption of minimally invasive surgical techniques due to increasing patient preference for less recovery time is a major market driver.

    Market Size & Forecast

    2024 Market Size 2.52 (USD Billion)
    2035 Market Size 4.23 (USD Billion)
    CAGR (2025-2035) 4.81%

    Major Players

    Revance Therapeutics, Ipsen, Allergan, Johnson and Johnson, Solta Medical, Hologic, Thermo Fisher Scientific, Aesthetic Surgical Innovations, Zeltiq Aesthetics, Galderma, Sientra, Sun Pharmaceutical Industries, Valeant Pharmaceuticals, Medytox, Mylan

    Gynecomastia Procedure Market Trends

    The Gynecomastia Procedure Market is experiencing significant growth driven by rising awareness of male breast conditions and advancements in surgical techniques. Increased visibility of body image issues, often influenced by social media and celebrity culture, is prompting more men to seek solutions for gynecomastia.

    Innovations in minimally invasive procedures have made surgeries safer and more appealing, contributing to a larger patient base. Additionally, the growing acceptance of cosmetic procedures among men is reducing the stigma associated with seeking treatment, leading to heightened demand in the market.

    Opportunities to be explored in the Gynecomastia Procedure Market lie in the expansion of telemedicine and the development of non-surgical treatment options. As telehealth gains traction, it offers a convenient way for potential patients to consult professionals, making procedures more accessible.

    Non-invasive techniques, such as liposuction or hormone therapy, present a less daunting approach for those hesitant about surgery. Moreover, increased investment in research and development can lead to more effective treatment protocols and technologies that cater to individual needs, further expanding market potential.

    Trends in recent times show a shift toward personalized treatments and a focus on patient satisfaction in treatment outcomes. Clinics are adopting a more holistic approach, emphasizing mental well-being alongside physical results.

    The trend of combining cosmetic procedures with mental health support is gaining traction, reflecting a broader understanding of the psychological impacts of body image. As the market continues to evolve, stakeholders are likely to focus on addressing both physical and emotional aspects of gynecomastia, making the overall patient experience more comprehensive and supportive.

    This trend signifies a future direction where treatments aim for not just aesthetic improvements but also enhanced self-confidence and quality of life for patients.

    The increasing awareness and acceptance of male breast reduction procedures suggest a growing demand for gynecomastia treatments, reflecting broader societal shifts towards body positivity and aesthetic enhancement.

    U.S. National Library of Medicine

    Gynecomastia Procedure Market Drivers

    Market Growth Projections

    Rising Awareness of Gynecomastia

    The increasing awareness regarding gynecomastia among the global population is a pivotal driver for the Global Gynecomastia Procedure Market Industry. As more individuals recognize the condition and its psychological impacts, there is a growing demand for surgical interventions. Educational campaigns and social media have played a significant role in disseminating information, leading to a surge in consultations with healthcare professionals. This heightened awareness is expected to contribute to the market's growth, with projections indicating a market value of 2.52 USD Billion in 2024, reflecting the urgent need for effective treatment options.

    Rising Incidence of Gynecomastia

    The rising incidence of gynecomastia, influenced by factors such as hormonal imbalances and lifestyle changes, is a critical driver for the Global Gynecomastia Procedure Market Industry. Conditions like obesity and certain medications contribute to the development of gynecomastia, leading to a higher prevalence of the condition. As more individuals seek treatment for this increasingly common issue, the demand for surgical procedures is expected to rise. This trend is likely to be reflected in the market's growth, with an anticipated value of 2.52 USD Billion in 2024, highlighting the urgent need for effective solutions.

    Expansion of Healthcare Infrastructure

    The expansion of healthcare infrastructure globally is facilitating access to gynecomastia treatments, thereby driving the Global Gynecomastia Procedure Market Industry. Improved healthcare facilities, coupled with the availability of specialized surgeons, are making it easier for patients to seek surgical interventions. This expansion is particularly evident in developing regions, where increased investment in healthcare is enhancing service delivery. As access to quality healthcare improves, more individuals are likely to pursue gynecomastia procedures, contributing to the market's projected growth trajectory.

    Increasing Male Aesthetic Consciousness

    The growing emphasis on male aesthetics is a notable driver within the Global Gynecomastia Procedure Market Industry. As societal norms shift, men are increasingly seeking cosmetic procedures to enhance their appearance and boost self-confidence. Gynecomastia, often associated with body image issues, is now being addressed more openly. This cultural shift is leading to a rise in demand for gynecomastia surgeries, as men prioritize their physical appearance. The market is projected to experience a compound annual growth rate (CAGR) of 4.81% from 2025 to 2035, reflecting the increasing acceptance of aesthetic procedures among men.

    Technological Advancements in Surgical Techniques

    Advancements in surgical techniques and technologies are transforming the landscape of the Global Gynecomastia Procedure Market Industry. Minimally invasive procedures, such as liposuction and gland excision, are gaining traction due to their reduced recovery times and improved patient outcomes. Innovations in surgical instruments and techniques enhance precision and safety, attracting more patients seeking treatment. As these technologies continue to evolve, they are likely to drive market growth significantly. The anticipated market value of 4.22 USD Billion by 2035 underscores the potential impact of these advancements on the industry.

    Market Segment Insights

    Gynecomastia Procedure Market Procedure Type Insights

    The Gynecomastia Procedure Market is expected to experience steady growth, particularly within the Procedure Type segment, which comprises various treatment options aimed at addressing gynecomastia. In 2023, the market was valued at approximately 2.29 USD Billion, highlighting a significant opportunity for growth across several key procedures.

    Among these, Liposuction holds a major share, with a valuation of 0.8 USD Billion, projected to rise to 1.25 USD Billion by 2032. This significant growth is attributed to its minimally invasive nature, appealing to patients seeking effective solutions with reduced recovery time.

    Mastectomy also plays a crucial role in the market, valued at 0.7 USD Billion in 2023 and anticipated to reach 1.1 USD Billion by 2032. This procedure is often favored for more severe cases of gynecomastia and addresses the physical discomfort and psychological impact associated with the condition.

    Another noteworthy procedure is Thyroid Hormone Therapy, generating a market valuation of 0.5 USD Billion, which is expected to increase to 0.75 USD Billion by 2032. This indicates its significance in treating gynecomastia caused by hormonal imbalances.

    Furthermore, the Medications sector, although smaller with a value of 0.24 USD Billion in 2023, is projected to grow to 0.4 USD Billion, reflecting the ongoing research into pharmaceutical interventions for managing gynecomastia. In contrast, Ultrasound devices, valued at 0.05 USD Billion, demonstrates a more niche application in the market, expected to reach 0.1 USD Billion by 2032, indicating limited but specialized usage in certain clinical scenarios.

    Get more detailed insights about Gynecomastia Procedure Market Research Report - Global Forecast till 2034

    Key Players and Competitive Insights

    The Gynecomastia Procedure Market is characterized by its competitive landscape, which is influenced by the increasing prevalence of gynecomastia among men and the growing awareness regarding aesthetic procedures. The market showcases a range of players including both specialized cosmetic surgical companies and pharmaceutical firms focusing on non-surgical options.

    Key industry trends include the adoption of advanced surgical techniques, minimally invasive procedures, and innovative pharmaceutical products that address the underlying hormonal issues associated with gynecomastia. As competition intensifies, companies are exploring strategic collaborations, mergers, and acquisitions to enhance their market presence and expand their product portfolios.

    Additionally, ongoing research and development efforts are crucial for firms seeking to address unmet patient needs and maintain a competitive edge in a rapidly evolving market landscape.

    Revance Therapeutics

    Revance Therapeutics stands out in the Gynecomastia Procedure Market with its strong focus on innovative treatment solutions for aesthetic procedures. The company has established a notable presence by developing advanced therapies that aim to provide effective results with minimal downtime.

    Revance's commitment to research and development enables it to stay at the forefront of technological advancements in gynecomastia treatment, enhancing patient experience and satisfaction. Moreover, the company has implemented strategic partnerships that have contributed to its market penetration and distribution capabilities.

    By offering competitive pricing and effective treatment solutions, Revance Therapeutics leverages its strengths to cater to a growing demographic seeking gynecomastia procedures, solidifying its position in the market.

    Ipsen

    Ipsen has made significant strides within the Gynecomastia Procedure Market, positioning itself as a recognizable player with a robust portfolio of treatments targeting gynecomastia. The company’s focus on innovation drives its efforts in developing new pharmacological approaches to manage gynecomastia, ensuring effective results for patients.

    Its established reputation in the pharmaceutical sector allows Ipsen to leverage its resources for extensive marketing and outreach, creating awareness about available treatments. Additionally, the company is known for its commitment to providing comprehensive support for healthcare professionals as well as patients navigating the complexities of gynecomastia.

    This approach aids in fostering trust and reliability, which are essential attributes in a competitive market landscape. Ipsen's strengths lie in its ability to blend pharmaceutical expertise with patient-centric care, allowing it to compete effectively in the gynecomastia treatment space.

    Key Companies in the Gynecomastia Procedure Market market include

    Industry Developments

    Recent developments in the Gynecomastia Procedure Market have shown a notable increase in demand for minimally invasive treatments, with advancements in technology contributing to enhanced safety and effectiveness. Companies such as Revance Therapeutics and Ipsen continue to progress in the development of injectable treatments aimed at reducing breast tissue in men, leading to a rise in market valuation.

    Additionally, Allergan and Johnson & Johnson have expanded their aesthetic product lines, catering to a growing consumer base seeking surgical and non-surgical solutions. Merger and acquisition activity includes Solta Medical's integration into a larger pharmaceutical portfolio to leverage its innovative technologies in the gynecomastia segment.

    Hologic and Thermo Fisher Scientific are exploring collaborative efforts to streamline treatment protocols in gynecomastia procedures, reflecting a trend toward consolidation and cooperative innovation in the market. Moreover, companies like Sientra and Galderma are focusing on improving patient outcomes through enhanced aftercare products and follow-up processes, influencing general market growth and consumer satisfaction.

    As a result, the Gynecomastia Procedure Market is experiencing a dynamic shift, with strong backing from advancements, mergers, and collaborative efforts that shape the landscape of men's health aesthetics.

    Future Outlook

    Gynecomastia Procedure Market Future Outlook

    The Gynecomastia Procedure Market is projected to grow at a 4.81% CAGR from 2025 to 2035, driven by rising awareness, technological advancements, and increasing disposable incomes.

    New opportunities lie in:

    • Develop minimally invasive techniques to enhance patient recovery and satisfaction.
    • Expand telemedicine services for pre- and post-operative consultations.
    • Invest in targeted marketing campaigns to raise awareness among younger demographics.

    By 2035, the Gynecomastia Procedure Market is expected to exhibit robust growth, reflecting evolving consumer needs and technological advancements.

    Market Segmentation

    Gynecomastia Procedure Market Gender Outlook

    • Male
    • Female

    Gynecomastia Procedure Market End User Outlook

    • Hospitals
    • Specialty Clinics
    • Ambulatory Surgical Centers

    Gynecomastia Procedure Market Regional Outlook

    • North America
    • Europe
    • South America
    • Asia Pacific
    • Middle East and Africa

    Gynecomastia Procedure Market Age Group Outlook

    • Adolescents
    • Adults
    • Elderly

    Gynecomastia Procedure Market Procedure Type Outlook

    • Liposuction
    • Mastectomy
    • Thyroid Hormone Therapy
    • Medications
    • Ultrasound

    Report Scope

    Report Attribute/Metric Details
    Market Size 2024    2.52 (USD Billion)
    Market Size 2025    2.64 (USD Billion)
    Market Size 2035 4.23 (USD Billion)
    Compound Annual Growth Rate (CAGR) 4.81% (2025 - 2035)
    Report Coverage Revenue Forecast, Competitive Landscape, Growth Factors, and Trends
    Base Year 2024
    Market Forecast Period 2025 - 2035
    Historical Data 2020 - 2024
    Market Forecast Units USD Billion
    Key Companies Profiled Revance Therapeutics, Ipsen, Allergan, Johnson and Johnson, Solta Medical, Hologic, Thermo Fisher Scientific, Aesthetic Surgical Innovations, Zeltiq Aesthetics, Galderma, Sientra, Sun Pharmaceutical Industries, Valeant Pharmaceuticals, Medytox, Mylan
    Segments Covered Procedure Type, End User, Gender, Age Group, Regional
    Key Market Opportunities Rising awareness of gynecomastia, Growing emphasis on body image, Technological advancements in procedures, Increase in male cosmetic surgeries, Expansion in emerging markets
    Key Market Dynamics Increasing prevalence of gynecomastia, Rising awareness and acceptance, Advancements in surgical techniques, Growing demand for cosmetic procedures, Increasing healthcare expenditure
    Countries Covered North America, Europe, APAC, South America, MEA

    FAQs

    What is the expected market size of the Gynecomastia Procedure Market in 2023?

    The Gynecomastia Procedure Market is expected to be valued at 2.29 USD Billion in 2023.

    What is the projected market size for the Gynecomastia Procedure Market by 2034?

    By 2034, the Gynecomastia Procedure Market is projected to reach a value of 4.03 USD Billion.

    What is the expected compound annual growth rate (CAGR) for the Gynecomastia Procedure Market from 2025 to 2034?

    The expected CAGR for the Gynecomastia Procedure Market from 2025 to 2034 is 4.81%.

    Which region holds the largest market share in the Gynecomastia Procedure Market in 2023?

    North America holds the largest market share in the Gynecomastia Procedure Market, valued at 0.95 USD Billion in 2023.

    What is the forecasted market value for the North American region by 2032?

    The market value for North America is forecasted to reach 1.45 USD Billion by 2032.

    Which procedure type is expected to have the highest market value in 2032?

    Liposuction is expected to have the highest market value, projected at 1.25 USD Billion in 2032.

    Who are the key players in the Gynecomastia Procedure Market?

    Key players in the Gynecomastia Procedure Market include Revance Therapeutics, Allergan, and Johnson Johnson.

    What is the anticipated market value for medications related to Gynecomastia procedures in 2032?

    The anticipated market value for medications in the Gynecomastia Procedure Market is projected to be 0.4 USD Billion by 2032.

    What is the expected market size for the Asia-Pacific (APAC) region in 2023?

    The expected market size for the APAC region in 2023 is 0.45 USD Billion.

    What are some emerging trends influencing the Gynecomastia Procedure Market?

    Emerging trends include advances in minimally invasive techniques and growing awareness of gynecomastia treatments.

    Download Free Sample

    Kindly complete the form below to receive a free sample of this Report

    Case Study
    Chemicals and Materials